Should further studies of chemotherapy be carried out in pancreatic cancer?
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference11 articles.
1. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer;Cancer,1987
2. Adjuvant radio-chemotherapy following resection of pancreatic adeno-carcinoma;Neoptolemos;Preliminary Results in Digestion,1992
3. Moertel CG, Childs DS Jr, Reitemeier RJ, et al. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet ii, 865–867.
4. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil) and high dose radiation + 5-fluorouracil;Cancer,1981
5. Surgical palliation combined with synchronous therapy in pancreatic carcinoma;Kahn;Eur J Surg Oncol,1990
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. 1,3-DEHYDROADAMANTANE AND ITS DERIVATIVES: A VERSATILE SYNTHETIC PLATFORM FOR PREPARATION OF FUNCTIONAL COMPOUNDS WITH A CAGE STRUCTURE. A REVIEW;Доклады Российской академии наук. Химия, науки о материалах;2023-07-01
2. PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) Regimen as Second-Line Therapy in Patients With Progressive or Recurrent Pancreatic Cancer After Gemcitabine-Containing Chemotherapy;American Journal of Clinical Oncology;2008-04
3. Quality of life assessment in advanced pancreatic adenocarcinoma: Results from a phase III randomized trial;Pancreatology;2006-10
4. What's new in pancreatic cancer treatment pipeline?;Best Practice & Research Clinical Gastroenterology;2006-04
5. Definitive Results of a Phase II Trial of Cisplatin, Epirubicin, Continuous-Infusion Fluorouracil, and Gemcitabine in Stage IV Pancreatic Adenocarcinoma;Journal of Clinical Oncology;2001-05-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3